Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Applied Materials -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (33274)	11/18/1999 4:21:00 PM
From: Cary Salsberg	Respond to of 70976

OT Sam, SFAM has been one of the threads I have followed for a long time. They are relatively cheap and have been so since last October '98. The merger with IPEC considerably lowered the quality of the balance sheet. Initially, I was correctly concerned about their ability to compete with AMAT. They seem to have largely failed. Then, I was intrigued by the idea of NVLS buying them to compete with AMAT and provide a second source for CMP. The apparent success of LRCX's Teres tool and the "relationship" between NVLS and LRCX makes me believe that it and followons will fill the role of second source to AMAT. Consequently, I have not and will not buy SFAM until clear signs of being able to compete emerge. If you need to buy "cheap", look at SVGI and UTEK, my two dogs and largest holdings in terms of number of shares. Cary